Reference
N'Dri L, et al. A Cost-Utility Analysis of Atovaquone-Proguanil vs. Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria in the United States. 23rd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PIN45, 19 May 2018. Available from: URL: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/81831?pdfid=55052
Rights and permissions
About this article
Cite this article
Atovaquone-proguanil: cost-effective choice for malaria in USA. PharmacoEcon Outcomes News 805, 8 (2018). https://doi.org/10.1007/s40274-018-5010-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5010-3